According to Perspective Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.09162. In 2022 the company made an earnings per share (EPS) of -$0.07000 a decrease over its 2021 EPS that were of -$0.05000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.09162 | 30.89% |
2022 | -$0.07000 | 40% |
2021 | -$0.05000 | -0% |
2020 | -$0.05000 | -16.67% |
2019 | -$0.06000 | -40% |
2018 | -$0.10 | -9.09% |
2017 | -$0.11 | -0% |
2016 | -$0.11 | 37.5% |
2015 | -$0.08000 | -27.27% |
2014 | -$0.11 | -15.38% |
2013 | -$0.13 | 8.33% |
2012 | -$0.12 | -0% |
2011 | -$0.12 | -20% |
2010 | -$0.15 | -25% |
2009 | -$0.20 | -33.33% |
2008 | -$0.30 | -33.33% |
2007 | -$0.45 | -26.23% |
2006 | -$0.61 | |
2004 | $0.03000 | -736.27% |
2003 | -$0.004715 | -98.67% |
2002 | -$0.35 | -168.8% |
2001 | $0.51 |